This startup develops a subcortical stimulator device for brain mapping during neurosurgery. The device helps healthcare professionals monitor patient responses to stimuli and integrates phenotypic and genomic data for speech, motor, sensory, and cognitive functions, aiding in precise surgical planning.
Funding
Funding not disclosed
Founders
Product
Problem
Intraoperative brain mapping, crucial for safe maximal tumor resection, is often inaccessible due to the high cost and operational complexity of existing cortical and subcortical stimulation devices. These limitations restrict the availability of brain mapping to well-funded clinics, hindering optimal surgical outcomes for patients in broader medical settings.
Solution
NeuroCarta is developing a handheld cortical/subcortical stimulator designed to make intraoperative brain mapping more accessible and efficient. The device provides neurosurgeons with greater control and feedback during procedures, while also reducing the personnel required for operation. By offering a more affordable and user-friendly solution, NeuroCarta aims to expand the availability of brain mapping, enabling safer and more complete tumor resections. The device's portability facilitates use across various hospital and clinic environments.
Target Audience
The primary target audience includes neurosurgeons and hospitals seeking affordable, portable, and user-friendly solutions for intraoperative brain mapping.
Features
- Handheld design for enhanced maneuverability and precision during brain mapping.
- User-oriented system providing real-time feedback to the neurosurgeon.
- Cost-effective pricing model to increase accessibility for a wider range of medical institutions.
- Lightweight and portable form factor for easy transport and use in different clinical settings.